https://www.jogeca.com/index.php/jogeca/issue/feed Journal of Obstetrics and Gynaecology of Eastern and Central Africa 2025-10-29T08:08:06+00:00 Editor-in-Chief editor-in-chief@jogeca.com Open Journal Systems <p><em><span style="font-weight: 400;">JOGECA </span></em><span style="font-weight: 400;">publishes original, peer-reviewed, research and reviews in Obstetrics and Gynecology. It also publishes work in basic and translational science relevant to reproductive biology and medicine. </span><em><span style="font-weight: 400;">JOGECA </span></em><span style="font-weight: 400;">provides a portal for work that fall under but not limited to Fetomaternal Medicine, Adolescent Health and Sexuality, Family Planning and Contraception, Gynecological Oncology, Fertility and Endocrinology, Urogynecology, Health Policy and Implementation Science, Information Technology in Health, Developmental Biology, Genomics, and Basic and Translational Science research.</span></p> https://www.jogeca.com/index.php/jogeca/article/view/503 Umbilical cord structural changes in Kenyan women with anemia diagnosed within the first 20 weeks of pregnancy: A retrospective cohort study. 2025-10-29T08:07:35+00:00 Felix Njoroge felixnjoroge6@gmail.com Beda Olabu otienobeda@gmail.com James Kigera jameskigera@yahoo.co.uk Anne Pulei nnpulei9@gmail.com <p class="western" align="justify"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Background:</strong></span></span></span> <span style="color: #000000;"><span style="font-family: Quadraat;">Gestational anemia is a global health concern. The initial 20 weeks of pregnancy are critical for the development and prevention of negative pregnancy outcomes related to low hemoglobin levels. </span></span></span></p> <p lang="en-US" align="justify"><span style="font-family: Quadraat;"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Objective</strong></span></span></span><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">:</span></span></span><span style="color: #000000;"> To compare the structural characteristics of the umbilical cord (UC) in women diagnosed with anemia in the first 20 weeks of pregnancy with those without anemia.</span></span></span></p> <p lang="en-US" align="justify"><span style="font-family: Quadraat;"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Methods</strong></span></span></span><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">: </span></span></span><span style="color: #000000;">This was a retrospective cohort study conducted at the Kenyatta National Hospital. Thirty-six umbilical cords were collected and examined for differences in gross and histological features. Comparisons were also made between the fetal and placental ends of the UC for these features.</span></span></span></p> <p lang="en-US" align="justify"><span style="font-family: Quadraat;"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Results</strong></span></span></span><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">:</span></span></span><span style="color: #000000;"> Significant differences were observed in the diameter of the umbilical cord, the volume of Wharton’s jelly, and the intima-media thickness of the umbilical vein (all p&lt;.05) between the anemic and nonanemic group. Disruption of the internal elastic lamina and intimal thickening of the umbilical vein were more prominent toward the fetal end of the UC in the anemia group. However, the increased risk of low birth weight in this group was not statistically significant, with a relative risk (RR) of 4.0 (95% CI: 0.49-32.39).</span></span></span></p> <p lang="en-US" align="justify"><span style="font-family: Quadraat;"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Conclusion</strong></span></span></span><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">: </span></span></span><span style="color: #000000;">Anemia within the first 20 weeks is associated with structural changes in the UC that may contribute to adverse outcomes. Improving hemoglobin levels before conception and during early pregnancy is therefore critical.</span></span></span></p> <p class="western" align="justify"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Keywords</strong></span></span></span><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">: </span></span></span><span style="color: #000000;"><span style="font-family: Quadraat;">adverse pregnancy outcomes, anemia, gestational anemia, low birth weight, umbilical cord.</span></span></span></p> 2025-09-30T00:00:00+00:00 Copyright (c) 2025 Felix Njoroge https://www.jogeca.com/index.php/jogeca/article/view/419 A fatal outcome following uterine perforation and pelvic abscess after hysterosalpingography: A case report 2025-10-29T08:07:50+00:00 Esther Nyambura esthernm73@gmail.com khushboo Sonigra krishnasarna@gmail.com Oscar Mwangi omugo8@gmail.com Evyonne Mutabari evymutabari@gmail.com Kireki Omanwa kirekiomanwa@gmail.com <p class="western" align="justify"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><span lang="en-US"><strong>Background:</strong></span></span></span></span> <span style="color: #000000;"><span style="font-family: Quadraat;"><span style="font-size: medium;"><span lang="en-US">Hysterosalpingography</span></span></span></span><span style="font-family: Quadraat;"><span style="font-size: medium;"> (HSG) is a widely used diagnostic tool in infertility evaluation. Although generally safe, it carries a rare risk of severe complications, including infections.</span></span></span></p> <p class="western" align="justify"><span style="font-family: Quadraat;"><span style="font-size: small;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Case presentation:</strong></span></span><span style="font-size: medium;"> A 43-year-old gravida 1 para 1, with secondary infertility for 15 years, presented with generalized body malaise, dyspnea, easy fatiguability, progressive abdominal pain, and noticeable abdominal swelling. The patient developed a pelvic abscess secondary to uterine perforation, two weeks after HSG. </span><span style="font-size: medium;">Despite antibiotic therapy and surgical drainage, her condition progressively deteriorated, culminating in septicemia and death.</span></span></span></p> <p class="western" align="justify"><span style="font-family: Quadraat;"><span style="font-size: small;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Conclusion: </strong></span></span><span style="font-size: medium;">Although rare, severe complications of HSG, such as uterine perforation and pelvic abscess, can be fatal. Early recognition and multidisciplinary management are essential to improve outcomes.</span></span></span></p> <p lang="en-US" align="justify"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Keywords: </strong><span style="font-family: Quadraat;"><span lang="en-US">Acinetobacter baumannii</span></span><span style="font-family: Quadraat;"><span lang="en-US">, media,</span></span> <span style="font-family: Quadraat;"><span lang="en-US">hysterosalpingography</span></span><span style="font-family: Quadraat;">, </span><span style="font-family: Quadraat;"><span lang="en-US">infertility, pelvic abscess</span></span><span style="font-family: Quadraat;">, </span><span style="font-family: Quadraat;"><span lang="en-US">postoperative complications</span></span></span></span></p> 2025-09-30T00:00:00+00:00 Copyright (c) 2025 Dr. Esther Nyambura, khushboo Sonigra, Dr. Oscar Mwangi, Dr. Evyonne Mutabari, Dr. Kireki Omanwa https://www.jogeca.com/index.php/jogeca/article/view/41 Peritoneal tuberculosis as a differential diagnosis for ovarian cancer: A case report 2025-10-29T08:07:58+00:00 RUKIA GANG'OMBE doctorukia@gmail.com Rukiya Abdulkadir ruky.abdulkadir@gmail.com Sylvia Mulandi slv.ndl@gmail.com Alfred Mokomba mokombadoc@gmail.com Edwin Walong edwin.walong@uonbi.ac.ke <p class="western" align="justify"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><span lang="en-US"><strong>Background:</strong></span></span></span></span> <strong><span style="color: #000000;"><span style="font-family: Quadraat;"><span style="font-size: medium;"><span lang="en-US">Peritoneal tuberculosis can closely mimic ovarian cancer in its clinical and radiologic presentation, particularly in high-tuberculosis</span></span></span></span></strong><span style="color: #000000;"><span style="font-family: Quadraat;"><span style="font-size: medium;">-</span></span></span><span style="color: #000000;"><span style="font-family: Quadraat;"><span style="font-size: medium;">burden regions, including</span></span></span> <span style="color: #000000;"><span style="font-family: Quadraat;"><span style="font-size: medium;">Kenya. Early recognition is key to avoid misdiagnosis and inappropriate management.</span></span></span></span></p> <p class="western" align="justify"><span style="font-family: Quadraat;"><span style="font-size: medium;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><strong>Case</strong></span></span> <span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><strong>presentation:</strong></span></span> <span style="color: #000000;">A 17-year-old presented with abdominal distension, pain, and unintentional weight loss. Imaging demonstrated bilateral complex ovarian masses, ascites, and peritoneal nodularity, with an elevated cancer antigen 125 (CA-125) level of 221 U/mL. Diagnostic laparoscopy revealed diffuse peritoneal tubercles, and biopsy confirmed granulomatous inflammation of peritoneal tissue with acid-fast</span> <span style="color: #000000;">bacilli consistent with peritoneal </span><span style="color: #000000;">tuberculosis.</span><span style="color: #000000;"> The patient showed marked clinical and radiological improvement after six months</span> <span style="color: #000000;">of</span><span style="color: #000000;"> standard </span><span style="color: #000000;">antituberculosis</span> <span style="color: #000000;">therapy.</span></span></span></p> <p class="western" align="justify"><span style="font-family: Quadraat;"><span style="font-size: medium;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><strong>Conclusion:</strong></span></span> Peritoneal tuberculosis is an important differential diagnosis for ovarian cancer. In high-prevalence settings such as Kenya, clinicians must maintain a high index of suspicion when evaluating patients with features suggestive of ovarian cancer to facilitate timely diagnosis and appropriate referral. </span></span></p> <p class="western" align="justify"><span style="font-family: Quadraat;"><span style="font-size: medium;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><strong>Keywords:</strong></span></span> <span style="color: #000000;">CA-125, </span><span style="color: #000000;">ovarian </span><span style="color: #000000;">cancer,</span><span style="color: #000000;"> peritoneal</span> <span style="color: #000000;">tuberculosis.</span></span></span></p> 2025-09-30T00:00:00+00:00 Copyright (c) 2025 RUKIA GANG'OMBE, Rukiya Abdulkadir, Sylvia Mulandi, Alfred Mokomba, Edwin Walong https://www.jogeca.com/index.php/jogeca/article/view/420 Pregnancy during adjuvant tamoxifen therapy: A case of temporary interruption and postpartum metastatic recurrence 2025-10-29T08:07:43+00:00 Morris Maganjo mmmaganjo@gmail.com Rose Kosgei salilkabon@gmail.com Humphrey Obwaya obwayahumphrey@gmail.com Allan Ikol ikolke9082@gmail.com Maurine Mutua maurinemutua@uonbi.ac.ke <p class="western" align="justify"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><span lang="en-US"><strong>Background:</strong></span></span></span></span> <span style="color: #000000;"><span style="font-family: Quadraat;"><span style="font-size: medium;"><span lang="en-US">Limited data exist regarding recurrence risk in pregnant women with hormone receptor-positive breast cancer who temporarily discontinue endocrine therapy. </span></span></span></span></span></p> <p class="western" align="justify"><span style="font-family: Quadraat;"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Case presentation:</strong></span></span></span><span style="color: #000000;"><span style="font-size: medium;"> A 37-year-old gravida 4, para 3, presented for antenatal care at 13 weeks’ gestation while</span></span><span style="color: #000000;"><span style="font-size: medium;"><span lang="en-GB"> on adjuvant tamoxifen, which she had taken for two months before conception. </span></span></span><span style="color: #000000;"><span style="font-size: medium;">Examination revealed a fundal height of 18 weeks and a healed mastectomy scar. Ultrasonography confirmed a dichorionic diamniotic twin pregnancy. Tamoxifen was discontinued, and pregnancy proceeded uneventfully until spontaneous preterm delivery at 34 weeks. Both neonates were clinically normal. Tamoxifen was resumed postpartum; however, 5 months after delivery, the patient developed metastatic recurrence and subsequently succumbed. </span></span></span></span></p> <p class="western" align="justify"><span style="font-family: Quadraat;"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Conclusion:</strong></span></span></span><span style="color: #000000;"><span style="font-size: medium;"> Pregnancy during breast cancer is not uncommon and poses complex clinical challenges. A multidisciplinary team is key to optimize maternal and neonatal outcomes.</span></span></span></span></p> <p class="western" align="justify"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Keywords: </strong></span></span></span><span style="color: #000000;"><span style="font-family: Quadraat;"><span style="font-size: medium;">breast cancer, endocrine therapy, metastasis, pregnancy, tamoxifen</span></span></span></span></p> 2025-09-30T00:00:00+00:00 Copyright (c) 2025 Dr. Morris Maganjo, Professor Rose Kosgei, Dr. Humphrey Obwaya, Dr. Allan Ikol, Dr. Maurine Mutua https://www.jogeca.com/index.php/jogeca/article/view/28 Rapidly growing primitive neuroectodermal tumor of the uterus causing obstructive uropathy in a 13-year-old African girl: A case report 2025-10-29T08:08:06+00:00 JOEL OOKO OJWANDO jojwando@students.uonbi.ac.ke Alfred Mokomba mokombadoc@gmail.com Eunice Cheserem cheserem@uonbi.ac.ke Edwin Walong edwin.walong@uonbi.ac.ke <p class="western" align="justify"><span style="font-size: small;"><span style="color: #000000;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><span lang="en-US"><strong>Background: </strong></span></span></span></span><span style="color: #000000;"><span style="font-family: Quadraat;"><span style="font-size: medium;"><span lang="en-US">Uterine </span></span></span></span><span style="font-family: Quadraat;"><span style="font-size: medium;"><span lang="en-US">primitive neuroectodermal tumors (PNETs) are</span></span></span> <span style="font-family: Quadraat;"><span style="font-size: medium;"><span lang="en-US">a</span></span></span><span style="font-family: Quadraat;"><span style="font-size: medium;"> rare group of embryonal tumors, with less than 100 cases reported, mostly in postmenopausal women. </span></span><span style="font-family: Quadraat;"><span style="font-size: medium;"><span lang="en-US">Their </span></span></span><span style="font-family: Quadraat;"><span style="font-size: medium;">rar</span></span><span style="font-family: Quadraat;"><span style="font-size: medium;"><span lang="en-US">ity poses diagnostic </span></span></span><span style="font-family: Quadraat;"><span style="font-size: medium;">and management challenges, contributing to</span></span> <span style="font-family: Quadraat;"><span style="font-size: medium;">high mortality</span></span><span style="font-family: Quadraat;"><span style="font-size: medium;"><span lang="en-US">. </span></span></span></span></p> <p class="western" align="justify"><span style="font-family: Quadraat;"><span style="font-size: small;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><span lang="en-US"><strong>Case presentation:</strong></span></span></span><span style="font-size: medium;"> A</span><span style="font-size: medium;"><span lang="en-US"> 13</span></span><span style="font-size: medium;">-year-old</span> <span style="font-size: medium;">presented with a 2-month history of abdominal pain, swelling, and heavy menstruation. Physical examination revealed a firm, fixed, nontender pelvic mass.</span> <span style="font-size: medium;">She underwent a panhysterectomy and nodal resection. Histopathology confirmed PNET. The tumor recurred within a month, and intraoperative spillage occurred during </span><span style="font-size: medium;">repeat surgery. She developed obstructive uropathy and succumbed approximately 11 months after initial presentation.</span></span></span></p> <p class="western" align="justify"><span style="font-family: Quadraat;"><span style="font-size: small;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><span lang="en-US"><strong>Conclusion:</strong></span></span></span><span style="font-size: medium;"> Uterine PNETs are aggressive tumors that rapidly infiltrate and obstruct pelvic structures. Owing to their rarity, diagnosis and management remain challenging, with high mortality. </span></span></span></p> <p class="western" align="justify"><span style="font-size: small;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Keywords:</strong></span></span><span style="font-family: Quadraat;"><span style="font-size: medium;"> embryonal tumors,</span></span> <span style="font-family: Quadraat;"><span style="font-size: medium;">obstructive uropathy, primitive</span></span> <span style="font-family: Quadraat;"><span style="font-size: medium;">neuroectodermal tumor, uterus</span></span></span></p> 2025-09-30T00:00:00+00:00 Copyright (c) 2025 JOEL OOKO OJWANDO, Dr. Mokomba, Pro. Cheresem, Dr. Walong